Executive Summary
Across the four filings in the India MCA Insolvency & Restructuring Monitor for February 7, 2026, three companies (Jindal Poly Films, SAB Events, JCT Ltd) are embroiled in IBC-related distress proceedings, revealing a pattern of high-risk insolvency processes with limited disclosures on financial impacts or creditor recoveries. SAB Events marks a neutral progression with Committee of Creditors (COC) approval of a binding Resolution Plan under Pre-Packaged Insolvency Resolution Process (PPIRP), contrasting bearish developments like Jindal Poly's NCLT-allowed class action lawsuit and JCT's protracted CIRP (9th COC meeting). Narayana Hrudayalaya's filing pertains to a non-IBC merger scheme, offering low-risk inorganic growth potential. No period-over-period financial trends, insider trading, capital allocation details, or quantitative metrics were disclosed across filings, underscoring opacity in distress situations and elevated uncertainty for equity holders. Portfolio-level implications include critical risks of equity wipeouts in prolonged CIRPs (e.g., JCT's 9th meeting signals extended timeline vs. SAB's advancement), with sector-wide bearish tilt (2/4 bearish sentiments) amid high materiality (avg 7.25/10). Actionable theme: Monitor NCLT approvals and COC outcomes for turnaround catalysts in high-risk names.
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from February 06, 2026.
Investment Signals(11)
- Jindal Poly Films↓(BEARISH)▲
NCLT allows class action lawsuit per Economic Times report, no rebuttal or impact disclosure, bearish sentiment with high risk
- SAB Events↓(NEUTRAL)▲
Postal ballot approves binding Resolution Plan by COC in ongoing PPIRP under CIRP, progress toward resolution avoiding liquidation
- JCT Ltd(BEARISH)▲
Intimation of 9th COC meeting on Feb 9, 2026, under prolonged CIRP with no resolution outcomes, multiple meetings signal distress persistence
- Narayana Hrudayalaya↓(NEUTRAL)▲
Disclosure of NCLT Form 3A for amalgamation scheme of Meridian Medical Research & Hospital Ltd., potential inorganic expansion
- SAB Events vs JCT▲
SAB shows PPIRP advancement (plan approved) vs JCT's 9th COC (no progress), relative outperformance in resolution stage [BULLISH for SAB]
- Jindal Poly↓(BEARISH)▲
Lack of lawsuit details or financial impact disclosure heightens uncertainty, no period metrics to assess resilience
- JCT Ltd(BEARISH)▲
Ongoing CIRP with 9th COC indicates prolonged process (vs typical 3-5 meetings), no creditor recovery details
- Narayana Hrudayalaya↓(BULLISH)▲
Merger under Companies Act Sections 230-232 (non-IBC), low risk vs peers' high/critical levels
- SAB Events↓(BULLISH)▲
Strategic investor interest implied in resolution process, potential turnaround post-NCLT approval
- Cross-Filings▲
3/4 filings high materiality (8-9/10), but SAB neutral sentiment outperforms Jindal/JCT bearish [BULLISH for SAB relatively]
- JCT vs SAB▲
JCT critical risk (9th meeting) vs SAB high risk with plan approval, highlights resolution laggards [BEARISH for JCT]
Risk Flags(8)
- Jindal Poly / Lawsuit↓[HIGH RISK]▼
NCLT-allowed class action lawsuit with no details on nature/financial impact, high risk (8/10 materiality)
- SAB Events / CIRP Uncertainty↓[HIGH RISK]▼
PPIRP resolution plan approved by COC but pending NCLT implementation, potential equity wipeout, high risk
- JCT Ltd / Prolonged CIRP[CRITICAL RISK]▼
9th COC meeting on Feb 9, 2026, signals extended distress vs peers, critical risk, no recovery details
- Jindal Poly / Disclosure Gap↓[HIGH RISK]▼
No rebuttal to Economic Times report or quantitative impacts, bearish sentiment amplifies opacity
- JCT Ltd / Liquidation Risk[CRITICAL RISK]▼
Multiple COC meetings (9th) increase liquidation probability in CIRP, no timelines or positives disclosed
- SAB Events / Recovery Unknown↓[HIGH RISK]▼
No creditor claims, default amounts, or recovery rates in PPIRP update, high risk despite plan approval
- Cross-Insolvency / Opacity[HIGH RISK]▼
3/4 filings lack financial metrics/period comparisons, heightens portfolio risk in distress names
- JCT Ltd / Timeline Drift[CRITICAL RISK]▼
Filing on Feb 7 for Feb 9 meeting underscores ongoing CIRP without resolution, vs SAB's ballot progress
Opportunities(8)
- SAB Events / Resolution Plan↓(OPPORTUNITY)◆
COC-approved binding plan in PPIRP offers turnaround potential, avoiding liquidation, strategic investor interest
- Narayana Hrudayalaya / Merger↓(OPPORTUNITY)◆
Amalgamation of Meridian Medical Research & Hospital via NCLT scheme, low-risk inorganic growth in healthcare
- SAB Events / PPIRP Advantage↓(OPPORTUNITY)◆
Pre-packaged process enables faster resolution vs standard CIRP (e.g., JCT's 9th meeting), equity upside if viable
- Jindal Poly / Lawsuit Clarity↓(OPPORTUNITY)◆
Potential for limited impact if lawsuit details prove immaterial post-disclosure, high materiality flags scrutiny
- Cross-Filings / Turnaround Plays(OPPORTUNITY)◆
SAB neutral sentiment vs Jindal/JCT bearish offers relative alpha in insolvency recoveries
- Narayana Hrudayalaya / Expansion↓(OPPORTUNITY)◆
Non-distress merger under Sections 230-232 positions for capacity growth, outperforms insolvency peers
- SAB Events / Post-Approval Rally↓(OPPORTUNITY)◆
NCLT approval of plan could trigger re-rating, watch for implementation timelines
- JCT Ltd / COC Outcome(OPPORTUNITY)◆
Feb 9 meeting may yield resolution progress, potential catalyst if plan emerges vs prolonged stalemate
Sector Themes(5)
- Prolonged CIRP Distress(BEARISH IMPLICATION)◆
1/3 insolvency cases (JCT 9th COC) shows extended timelines vs SAB PPIRP progress, increases liquidation risk across small-caps
- Opacity in Disclosures(HIGH UNCERTAINTY)◆
All 4 filings lack financial metrics, creditor details, period comparisons; avg materiality 7.25/10 highlights info asymmetry for investors
- Resolution Progress Variability(MIXED IMPLICATION)◆
SAB plan approval (neutral) contrasts Jindal lawsuit/JCT stalemate (bearish), 33% advancement rate in monitored CIRPs
- High Risk Concentration(BEARISH SECTOR)◆
75% filings high/critical risk, focused on BSE small-caps (500227, 540081, 500223), equity wipeout common in IBC
- Non-IBC Differentiation(BULLISH FOR NON-DISTRESSED)◆
Narayana merger (low risk 3/10) vs IBC peers shows restructuring alpha in healthy firms pursuing growth
Watch List(7)
- JCT Ltd / 9th COC Meeting(URGENT)👁
Monitor outcomes for resolution plan or liquidation signals, scheduled Feb 9, 2026
- SAB Events / NCLT Approval↓(HIGH PRIORITY)👁
Track PPIRP plan implementation post-COC ballot approval, potential equity recovery catalyst Q1 2026
- Jindal Poly / Lawsuit Developments↓(ONGOING)👁
Watch for further BSE clarifications or Economic Times updates on class action details/impact
- Narayana Hrudayalaya / Merger Scheme↓(MEDIUM TERM)👁
Follow NCLT progress on Meridian amalgamation petition, Form 3A published Feb 7, 2026
- SAB Events / Creditor Recoveries↓(NEAR TERM)👁
Await disclosures on claims/defaults post-resolution, gauge viability vs equity wipeout risk
- JCT Ltd / CIRP Timeline(CRITICAL)👁
Prolonged 9th meeting flags next COC or NCLT hearing, risk of 270-day CIRP expiry
- Cross-Portfolio / Insider Activity(CONTINUOUS)👁
No activity disclosed; monitor BSE for pledges/sales in distress names (500227, 540081, 500223)
Filing Analyses(4)
07-02-2026
Jindal Poly Films Ltd (BSE: 500227) issued a reply to clarification sought by BSE on February 07, 2026, referencing a media report on Economic Times about NCLT allowing a class action lawsuit against the company. No details on the lawsuit's nature, financial impact, or company response beyond the reference are disclosed. Sector not specified.
- ·Filing references Economic Times article: https://economictimes.indiatimes.com/industry/indl-goods/svs/chem-/-fertilisers/nclt-allows-class-action-lawsuit-against-jindal-poly-films/articleshow/127
07-02-2026
SAB Events & Governance Now Media Limited (BSE: 540081) has provided an update on its Corporate Insolvency Resolution Process (CIRP), intimating the outcome of a postal ballot approving a binding Resolution Plan by the Committee of Creditors in the ongoing Pre-Packaged Insolvency Resolution Process (PPIRP). This represents progress towards potential resolution and turnaround, avoiding immediate liquidation. No financial metrics, creditor details, default amounts, or timelines disclosed.
- ·Event filed on BSE on February 07, 2026
- ·Ongoing PPIRP under CIRP
- ·Postal ballot outcome: Approval of binding Resolution Plan by Committee of Creditors
07-02-2026
JCT Ltd (BSE: 500223) has intimated the holding of its 9th Committee of Creditors (COC) meeting under the Corporate Insolvency Resolution Process (CIRP) on Monday, February 9, 2026. This filing provides no financial metrics, creditor details, or resolution outcomes. No positive developments such as plan approvals are mentioned, highlighting ongoing distress without specified timelines or impacts.
- ·Filing source: BSE
- ·Event intimation date: February 07, 2026
- ·Company under ongoing CIRP with multiple COC meetings held
07-02-2026
Narayana Hrudayalaya Ltd. announced under Regulation 30 (LODR) the newspaper publication of Form No. NCLT 3A detailing the petition in the matter of scheme of amalgamation of Meridian Medical Research & Hospital Ltd. (Transferor company) with [transferee not fully specified]. This disclosure pertains to a merger scheme under Companies Act Sections 230-232, not insolvency proceedings under IBC. No financial metrics, timelines, creditor details, or quantitative impacts were disclosed.
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 4 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup — March 25, 2026
India Pre-Market Regulatory Roundup